ARCUTIS BIOTHERAPEUTICS INC (ARQT) Institutional Shareholders
ARCUTIS BIOTHERAPEUTICS INC (ARQT) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $3.08B in ARQT holdings during the latest filing period.
Suvretta Capital Management, Llc is currently the largest disclosed institutional shareholder of ARQT tracked by InsiderSet, reporting ownership valued at approximately $290.42M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $331.10M, representing an estimated gain of +14.01% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 54% of the total disclosed ARQT value among the investors covered in this analysis. Major shareholders include Suvretta Capital Management, Llc, Frazier Life Sciences Management, L.P., Blackrock, Inc., and several other long-term asset managers with concentrated positions in ARCUTIS BIOTHERAPEUTICS INC (ARQT).
This page ranks the largest institutional ARQT shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
253
Total Reported Value
$3.08B
Largest Holder
Suvretta Capital Management, Llc
Largest Position
$290.42M
Insider Transactions (90d)
19
Latest Filing Quarter
Q2 2026
New Institutional Positions
78
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Suvretta Capital Management, Llc | 7.88% | 12,327,000 | $290,424,120 | $331,103,220 | +$40,679,100 | +14.01% | |
| Frazier Life Sciences Management, L.P. | 5.99% | 9,874,511 | $232,643,479 | $265,229,365 | +$32,585,886 | +14.01% | |
| Blackrock, Inc. | 0.00% | 9,200,411 | $216,761,686 | $247,123,039 | +$30,361,353 | +14.01% | |
| Rubric Capital Management Lp | 2.39% | 8,271,577 | $194,878,354 | $222,174,558 | +$27,296,204 | +14.01% | |
| State Street Corp | 0.01% | 6,296,197 | $148,338,401 | $169,115,851 | +$20,777,450 | +14.01% | |
| Polar Capital Holdings Plc | 0.58% | 5,666,940 | $133,513,106 | $152,214,008 | +$18,700,902 | +14.01% | |
| Jennison Associates Llc | 0.08% | 4,980,770 | $117,346,943 | $133,783,482 | +$16,436,539 | +14.01% | |
| Vanguard Capital Management Llc | 0.00% | 4,871,536 | $114,773,388 | $130,849,457 | +$16,076,069 | +14.01% | |
| Gilder Gagnon Howe & Co Llc | 1.22% | 4,304,010 | $101,402,476 | $115,605,709 | +$14,203,233 | +14.01% | |
| Morgan Stanley | 0.01% | 4,218,931 | $99,398,031 | $113,320,487 | +$13,922,456 | +14.01% | |
| Ubs Group Ag | 0.01% | 3,329,224 | $78,436,518 | $89,422,957 | +$10,986,439 | +14.01% | |
| Geode Capital Management, Llc | 0.00% | 3,045,306 | $71,759,223 | $81,796,919 | +$10,037,696 | +13.99% | |
| D. E. Shaw & Co., Inc. | 0.05% | 2,496,222 | $58,810,990 | $67,048,523 | +$8,237,533 | +14.01% | |
| Marshall Wace, Llp | 0.06% | 2,431,778 | $57,292,689 | $65,317,557 | +$8,024,868 | +14.01% | |
| Franklin Resources Inc | 0.01% | 2,297,943 | $54,139,548 | $61,722,749 | +$7,583,201 | +14.01% | |
| Driehaus Capital Management Llc | 0.39% | 2,226,029 | $52,445,243 | $59,791,139 | +$7,345,896 | +14.01% | |
| Bank Of America Corp | 0.00% | 2,221,289 | $52,333,569 | $59,663,823 | +$7,330,254 | +14.01% | |
| Vanguard Portfolio Management Llc | 0.00% | 1,954,685 | $46,052,379 | $52,502,839 | +$6,450,460 | +14.01% | |
| Janus Henderson Group Plc | 0.02% | 1,854,566 | $43,684,303 | $49,813,643 | +$6,129,340 | +14.03% | |
| Goldman Sachs Group Inc | 0.00% | 1,603,013 | $37,766,986 | $43,056,929 | +$5,289,943 | +14.01% | |
| American Century Companies Inc | 0.02% | 1,463,228 | $34,473,689 | $39,302,304 | +$4,828,615 | +14.01% | |
| Oberweis Asset Management Inc/ | 0.95% | 1,365,941 | $32,181,570 | $36,689,175 | +$4,507,605 | +14.01% | |
| Pivotal Bioventure Partners Investment Advisor Llc | 11.42% | 1,355,892 | $31,944,816 | $36,419,259 | +$4,474,443 | +14.01% | |
| Ensign Peak Advisors, Inc | 0.05% | 1,244,387 | $29,317,758 | $33,424,235 | +$4,106,477 | +14.01% | |
| Perpetual Ltd | 0.42% | 1,109,657 | $29,095,206 | $29,805,387 | +$710,181 | +2.44% | |
| Aberdeen Group Plc | 0.04% | 1,098,411 | $28,800,336 | $29,503,319 | +$702,983 | +2.44% | |
| Squarepoint Ops Llc | 0.06% | 1,103,490 | $25,998,224 | $29,639,741 | +$3,641,517 | +14.01% | |
| Candriam S.C.A. | 0.13% | 1,086,651 | $25,601,498 | $29,187,446 | +$3,585,948 | +14.01% | |
| Federated Hermes, Inc. | 0.04% | 1,077,267 | $25,380,411 | $28,935,392 | +$3,554,981 | +14.01% | |
| Bamco Inc | 0.08% | 1,072,189 | $25,260,773 | $28,798,997 | +$3,538,224 | +14.01% | |
| Charles Schwab Investment Management Inc | 0.00% | 1,012,555 | $23,855,796 | $27,197,227 | +$3,341,431 | +14.01% | |
| Northern Trust Corp | 0.00% | 976,512 | $23,006,622 | $26,229,112 | +$3,222,490 | +14.01% | |
| Nuveen, Llc | 0.01% | 902,134 | $21,254,278 | $24,231,319 | +$2,977,041 | +14.01% | |
| Bnp Paribas Financial Markets | 0.01% | 812,146 | $19,134,160 | $21,814,242 | +$2,680,082 | +14.01% | |
| Vanguard Fiduciary Trust Co | 0.00% | 771,764 | $18,182,760 | $20,729,581 | +$2,546,821 | +14.01% | |
| Mpm Bioimpact Llc | 1.34% | 733,966 | $17,292,239 | $19,714,327 | +$2,422,088 | +14.01% | |
| Qube Research & Technologies Ltd | 0.02% | 724,067 | $17,059,019 | $19,448,440 | +$2,389,421 | +14.01% | |
| Fishman Jay A Ltd/Mi | 1.24% | 595,005 | $15,601,031 | $15,981,834 | +$380,803 | +2.44% | |
| Healthcare Of Ontario Pension Plan Trust Fund | 0.02% | 636,200 | $14,988,872 | $17,088,332 | +$2,099,460 | +14.01% | |
| Nearwater Capital Markets, Ltd | 0.34% | 607,300 | $14,307,988 | $16,312,078 | +$2,004,090 | +14.01% | |
| Point72 Asset Management, L.P. | 0.02% | 590,877 | $13,921,062 | $15,870,956 | +$1,949,894 | +14.01% | |
| Eversept Partners, Lp | 0.90% | 576,580 | $13,584,225 | $15,486,939 | +$1,902,714 | +14.01% | |
| Voloridge Investment Management, Llc | 0.05% | 540,511 | $12,734,439 | $14,518,125 | +$1,783,686 | +14.01% | |
| Manufacturers Life Insurance Company, The | 0.01% | 503,856 | $11,870,847 | $13,533,572 | +$1,662,725 | +14.01% | |
| Capitolis Liquid Global Markets Llc | 0.07% | 500,000 | $11,780,000 | $13,430,000 | +$1,650,000 | +14.01% | |
| M&G Plc | 0.06% | 469,082 | $11,257,968 | $12,599,543 | +$1,341,575 | +11.92% | |
| Aqr Capital Management Llc | 0.01% | 468,253 | $11,032,040 | $12,577,276 | +$1,545,236 | +14.01% | |
| Cormorant Asset Management, Lp | 0.53% | 450,000 | $10,602,000 | $12,087,000 | +$1,485,000 | +14.01% | |
| Renaissance Technologies LLC | Jim Simons | 0.02% | 440,999 | $10,389,936 | $11,845,233 | +$1,455,297 | +14.01% |
| Stempoint Capital Lp | 1.90% | 413,792 | $9,748,940 | $11,114,453 | +$1,365,513 | +14.01% |
Frequently asked questions about ARQT
Who owns the most ARQT stock?
The largest holders of ARQT are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for ARCUTIS BIOTHERAPEUTICS INC (ARQT).
Is ARQT widely held by superinvestors?
Many widely followed stocks like ARQT appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly ARQT is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.